Deadline extended: Survey on understanding the gaps in SACT education to minority group cancer patients

The deadline to respond to the survey has been extended to Friday 15th December.

The aim of the wider project is to develop recommendations of areas that should be incorporated into pharmacy staff teaching. I would be very grateful if you could complete this questionnaire to understand the gaps that exist when educating a patient from a minority group, receiving systemic anticancer therapy (SACT). 

If you have any questions about this project then please email me via: [email protected]

It should take 10-15minutes to complete. All responses will be anonymous.

https://forms.office.com/e/CwQwB45j0Z

 

Many thanks for your participation!

Apini Patel

Senior Oncology Pharmacist 

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article